Exozymes

EXOZNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$38.242 M

$4.11 -5.95%

Close of 6 Nov 2026

As of 6 Nov 2026, Exozymes (EXOZ) has a market capitalization of $38.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$9.16M

Loss-making

Shares outstanding

9,281,359

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#128Caribou BiosciencesCRBU$44.2M
#129LeonaBioLONA$40.8M
#130ExozymesEXOZ$38.2M
#131Inmune BioINMB$36.8M
#132Pelthos TherapeuticsPTHS$36.7M

What if Exozymes were worth as much as…

Open the what-if tool →

Gold $28.2T

$3,034,689

Per share 738,367× higher

Bitcoin $1.53T

$164,201.74

Per share 39,952× higher

Apple $5.02T

$539,058.98

Per share 131,158× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Exozymes are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.